Cutaneous Markers of Cardiovascular Diseases
DOI:
https://doi.org/10.20344/amp.18108Keywords:
Cardiovascular Diseases, Skin ManifestationsAbstract
Cardiovascular diseases are one of the most important global medical challenges because of their high rates of morbidity and mortality. In this narrative review, the authors address the most important dermatologic signs that can be present in patients with cardiovascular disease. The early recognition of these underestimated entities is very important as it may lead to an early diagnosis and timely treatment, thus lessening the effects of long-term disease and possibly improving the prognosis.
Downloads
References
Dahlöf B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol. 2010;105:3A-9. DOI: https://doi.org/10.1016/j.amjcard.2009.10.007
Saksena F. Local and systemic manifestations of cardiovascular disease. In: Ranganattan NSivaciyan V, Saksena F, editors. The art and science of cardiac physical examination. New Jersey: Humana Press; 2007. p.361-95. DOI: https://doi.org/10.1007/978-1-59745-023-2_11
Uliasz A, Lebwohl M. Cutaneous manifestations of cardiovascular diseases. Clin Dermatol. 2008;26:243-54. DOI: https://doi.org/10.1016/j.clindermatol.2007.10.014
Mcdonnell JK. Cardiac disease and the skin. Dermatol Clin. 2002;20:503-11. DOI: https://doi.org/10.1016/S0733-8635(02)00007-4
Chan HL. Cutaneous manifestations of cardiac diseases. Singapore Med J. 1990;31:480-85.
Trayes KP, Studdiford JS. Edema: diagnosis and management. Am Fam Physician. 2013;88:102-10.
O’Gara PT, Loscalzo J. Physical examination of the cardiovascular system. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018 p.1666-75.
Inamdar A, Inamdar A. Heart failure: diagnosis, management and utilization. J Clin Med. 2016;5:62. DOI: https://doi.org/10.3390/jcm5070062
Stone J, Hangge P, Albadawi H, Wallace A, Shamoun F, Knuttien M, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther. 2017;7:S277-84. DOI: https://doi.org/10.21037/cdt.2017.09.01
O’Gara PT, Loscalzo J. Hypoxia and cyanosis. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018.p.234-7.
Spicknall KE, Zirwas MJ, English JC. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005;52:1020-8. DOI: https://doi.org/10.1016/j.jaad.2005.01.006
Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234:1-12. DOI: https://doi.org/10.1002/jcp.28350
Dwivedi S. Cutaneous markers of coronary artery disease. World J Cardiol. 2010;2:262. DOI: https://doi.org/10.4330/wjc.v2.i9.262
Wagner Jr RF, Wagner KD. Cutaneous signs of coronary artery disease. Int J Dermatol. 1983;22:215-20. DOI: https://doi.org/10.1111/j.1365-4362.1983.tb03370.x
Schwarzenberger K, Callen J. Dermatologic manifestations in patients with systemic disease. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Amsterdam: Elsevier; 2018:819-43.
Forrestel A, Micheletti R. Skin manifestations of internal organ disorders. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, Michael AJ, et al, editors. Fitzpatrick’s dermatology. 9th ed. New York: McGraw-Hill; 2019:2425-40.
Davis TM, Stuccio G, Balme M, Bruce DG, Jackson D. The diagonal ear lobe crease (Frank’s sign) is not associated with coronary artery disease or retinopathy in type 2 diabetes: the Frernantle Diabetes Study. Aust N Z J Med. 2000;30:573-7. DOI: https://doi.org/10.1111/j.1445-5994.2000.tb00858.x
Frank ST. Aural sign of coronary artery disease. N Engl J Med. 1973;289:327-8. DOI: https://doi.org/10.1056/NEJM197308092890622
Shoenfeld Y, Mor R, Weinberger A, Pinkhas J. Diagonal ear lobe crease and coronary risk factors. J Am Geriatr Soc. 1980;28:184-7. DOI: https://doi.org/10.1111/j.1532-5415.1980.tb00514.x
Sanches MM, Roda Â, Pimenta R, Filipe PL, Freitas JP. Cutaneous manifestations of diabetes mellitus and prediabetes. Acta Med Port. 2019;32:459-65. DOI: https://doi.org/10.20344/amp.10738
Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112:432-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.532498
Akinseye OA, Pathak A, Ibebuogu UN. Aortic valve regurgitation: a comprehensive review. Curr Probl Cardiol. 2018;43:315-34. DOI: https://doi.org/10.1016/j.cpcardiol.2017.10.004
Iung B, Duval X. Infective endocarditis: innovations in the management of an old disease. Nat Rev Cardiol. 2019;16:623-35. DOI: https://doi.org/10.1038/s41569-019-0215-0
Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, et al. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol. 2014;150:494-500. DOI: https://doi.org/10.1001/jamadermatol.2013.8727
Gunson TH, Oliver GF. Osler’s nodes and Janeway lesions. Australas J Dermatol. 2007;48:251-5. DOI: https://doi.org/10.1111/j.1440-0960.2007.00397.x
Pepe G, Giusti B, Sticchi E, Abbate R, Gensini GF, Nistri S. Marfan syndrome: current perspectives. Appl Clin Genet. 2016;9:55-65. DOI: https://doi.org/10.2147/TACG.S96233
Pyeritz RE. The Marfan syndrome. Annu Rev Med. 2000;51:481-510. 28. Sulli A, Talarico R, Scirè CA, Avcin T, Castori M, Ferraris A, et al. Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. RMD Open. 2018;4:1-6. DOI: https://doi.org/10.1136/rmdopen-2018-000790
Beighton P. The dominant and recessive forms of cutis laxa. J Med Genet. 1972;9:216-21. DOI: https://doi.org/10.1136/jmg.9.2.216
Mohamed M, Voet M, Gardeitchik T, Morava E. Cutis laxa. Adv Exp Med Biol. 2014;802:161-84. DOI: https://doi.org/10.1007/978-94-007-7893-1_11
Stumpf MJ, Schahab N, Nickenig G, Skowasch D, Schaefer CA. Therapy of pseudoxanthoma elasticum: current knowledge and future perspectives. Biomedicines. 2021;9:1895. DOI: https://doi.org/10.3390/biomedicines9121895
Denayer E, Legius E. What’s new in the neuro-cardio-facial-cutaneous syndromes? Eur J Pediatr. 2007;166:1091-8. DOI: https://doi.org/10.1007/s00431-007-0535-7
Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18:383-90. DOI: https://doi.org/10.1007/s40257-016-0250-0
Nicholls SC. Sequelae of untreated venous insufficiency. Semin Intervent Radiol. 2005;22:162-8. DOI: https://doi.org/10.1055/s-2005-921960
Santler B, Goerge T. Chronic venous insufficiency – a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15:538-56. DOI: https://doi.org/10.1111/ddg.13242
Herouy Y, Mellios P, Bandemir E, Dichmann S, Nockowski P, Schopf E, et al. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci. 2001;25:198-205. DOI: https://doi.org/10.1016/S0923-1811(00)00128-6
Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol. 2009;61:1028-32. DOI: https://doi.org/10.1016/j.jaad.2009.04.025
Francès C, Niang S, Laffitte E, le Pelletier F, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52:1785-93. DOI: https://doi.org/10.1002/art.21041
Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, et al. Antiphospholipid syndrome. Nat Rev Dis Primers. 2018;4. DOI: https://doi.org/10.1038/nrdp.2017.103
Pinto-Almeida T, Caetano M, Sanches M, Selores M. Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management. Acta Reumatol Port. 2013;32:10-8.
Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:1-24. DOI: https://doi.org/10.1038/nrdp.2015.84
Cunningham MW. Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group a streptococci and their sequelae. Microbiol Spectr. 2019;7:10.1128/microbiolspec.GPP3-0045-2018. DOI: https://doi.org/10.1128/microbiolspec.GPP3-0045-2018
Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography a scientific statement from the American heart association. Circulation. 2015;131:1806-18. DOI: https://doi.org/10.1161/CIR.0000000000000205
Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. N Engl J Med. 2020;382:845-54. DOI: https://doi.org/10.1056/NEJMra1901593
Lukehart S. Syphilis. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018. p.1279-86.
Kreps A, Paltoo K, McFarlane I. Cardiac manifestations in systemic lupus erythematosus: a case report and review of the literature. Am J Med Case Rep. 2018;6:180-3. DOI: https://doi.org/10.12691/ajmcr-6-9-3
Jarrett P, Werth VP. A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach. J Multidiscip
Healthc. 2019;12:419-28.
Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009;62:584-92. DOI: https://doi.org/10.1136/jcp.2009.064311
Dietz SM, van Stijn D, Burgner D, Levin M, Kuipers IM, Hutten BA, et al. Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr. 2017;176:995-1009. DOI: https://doi.org/10.1007/s00431-017-2937-5
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2743-71. DOI: https://doi.org/10.1161/01.CIR.0000145143.19711.78
Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685-99. DOI: https://doi.org/10.1016/S0140-6736(17)30933-9
Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Intern Emerg Med. 2018;13:325-31. DOI: https://doi.org/10.1007/s11739-017-1778-6
Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician. 2002;5:1581-4.
DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol. 2020;82:267-81. DOI: https://doi.org/10.1016/j.jaad.2019.06.1309
Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment. J Am Acad Dermatol. 2020;82:283-96. DOI: https://doi.org/10.1016/j.jaad.2019.05.105
Hruza LL, Hruza GJ. Saphenous vein graft donor site dermatitis case reports and literature review. Arch Dermatol. 1993;129:609-12. DOI: https://doi.org/10.1001/archderm.129.5.609
Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part I. Cardiol Rev. 2002;10:230-46. DOI: https://doi.org/10.1097/00045415-200207000-00008
Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part II. Cardiol Rev. 2002;10:285-300. DOI: https://doi.org/10.1097/00045415-200209000-00005
Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev. 2002;10:337-48. DOI: https://doi.org/10.1097/00045415-200211000-00006
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
